Jp.medical Dy.mark. Stock
Jp.medical Dy.mark. Stock
A loss of -1.960% shows a downward development for Jp.medical Dy.mark..
Criterium "Business model" is seen as the biggest plus for Jp.medical Dy.mark. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Jp.medical Dy.mark. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jp.medical Dy.mark. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jp.medical Dy.mark. | -1.960% | 15.385% | 17.188% | -19.355% | 18.110% | -57.447% | -80.392% |
| Cardiff Oncology Inc. | -0.720% | 1.331% | -43.035% | -69.351% | -45.418% | -22.071% | -85.803% |
| Electrocore Inc. | 0.810% | 11.111% | -13.793% | 36.370% | 30.890% | 36.370% | -85.104% |
| Elexxion AG | 0.000% | 1.429% | -30.392% | -40.833% | -38.528% | -69.130% | -72.692% |